Skip to main navigation Skip to search Skip to main content

Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae

  • R Anderson
  • , H C Steel
  • , R Cockeran
  • , A M Smith
  • , A von Gottberg
  • , L de Gouveia
  • , A Brink
  • , K P Klugman
  • , T J Mitchell
  • , C Feldman

Research output: Contribution to journalArticlepeer-review

34 Citations (Scopus)

Abstract

To investigate the effects of clarithromycin (0.01-0.5 mg/L) alone or in combination with ceftriaxone (0.1 and 0.25 mg/L) on pneumolysin production by both macrolide-susceptible and -resistant [2 erm(B) positive and 2 mef(A) positive] strains of Streptococcus pneumoniae.
Original languageEnglish
Pages (from-to)224-9
Number of pages6
JournalJournal of Antimicrobial Chemotherapy
Volume59
Issue number2
DOIs
Publication statusPublished - Feb 2007

Keywords

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Ceftriaxone
  • Clarithromycin
  • Dose-Response Relationship, Drug
  • Drug Resistance, Bacterial
  • Drug Synergism
  • Microbial Sensitivity Tests
  • Polymerase Chain Reaction
  • Streptococcus pneumoniae
  • Streptolysins

Fingerprint

Dive into the research topics of 'Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae'. Together they form a unique fingerprint.

Cite this